2110 NARCISSUS CT, VENICE, CA
Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Stockholders Approve Amendment to 2023 Stock Incentive Plan
Other Events
Announces Closing of $60 Million Public Offering of Common Stock
Reg. FD, Other Events
Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
Changes in Board, Management or Compensation
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
S-1
Direct Registration System
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence